Charles Heise | Associate Director, Bioprocessing Strategy & Development
FUJIFILM Biotechnologies

Charles Heise is Associate Director in the Bioprocessing Strategy & Development group at FUJIFILM Biotechnologies working on developing connected, integrated processes. He has over 15 years of experience in the biologics industry leading the development of cGMP processes for clinical and commercial recombinant protein manufacture and academic research collaborations. He is co-inventor of the award winning SymphonXTM purification skid and the downstream technical lead for Fujifilm’s continuous biomanufacturing platform, MaruXTM. Charles graduated in the UK from the University of Oxford and obtained his doctorate from the University of York.

Appearances:

Festival of Biologics Day 1 @ 11:55

KojoX - A Transformative Operational Ecosystem Delivering Flexible Manufacturing Strategies and Security of Supply

Leveraging Biologics manufacturing capacity for supply of life impacting or saving medicine is the key to a flexible supply chain that can respond to unforeseen demand changes. FUJIFILM Biotechnologies’ kojoX™ operational ecosystem is transforming the CDMO industry, delivering across a globally harmonized network and over a range of scales. KojoX is founded on using standardized infrastructure and processes to enable rapid transfer and production of medicines across one global network. However, the constantly evolving landscape driven by scientific and technological advances requires flexibility within this kojoX framework.

The presentation will outline the tools and strategies Fujifilm deploy to integrate current ways of working with innovation activities to ensure future technical solutions and processing strategies can be effectively and efficiently deployed into the kojoX ecosystem to solve today’s challenges as well as future patient needs.

Charles Heise, Associate Director, Bioprocessing Strategy & Development, FUJIFILM Biotechnologies